AR046410A1 - Composiciones farmaceuticas para la liberacion modificada de modafinilo - Google Patents
Composiciones farmaceuticas para la liberacion modificada de modafiniloInfo
- Publication number
- AR046410A1 AR046410A1 ARP040103336A ARP040103336A AR046410A1 AR 046410 A1 AR046410 A1 AR 046410A1 AR P040103336 A ARP040103336 A AR P040103336A AR P040103336 A ARP040103336 A AR P040103336A AR 046410 A1 AR046410 A1 AR 046410A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical compositions
- patient
- modafinilo
- dosage form
- modafinil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Abstract
Composiciones farmacéuticas que contienen modafinilo. Método de preparación de un sistema de administración de fármacos. Método de tratamiento de un paciente. Reivindicación 1: Una composición farmacéutica en forma de dosis unitaria, donde, al ser administrada a un paciente, la composición libera dos o más cantidades de un compuesto modafinilo. Reivindicación 2: La composición farmacéutica de la reivindicación 1, donde, al ser administrada a un paciente, la forma de dosificación unitaria libera una primera cantidad efectiva de un compuesto de modafinilo, seguido de un intervalo de tiempo durante el cual no se libera substancialmente nada de compuesto de modafinilo de la forma de dosificación y después de cuyo intervalo de tiempo se libera una segunda cantidad de compuesto de modafinilo de la forma de dosificación.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50402803P | 2003-09-18 | 2003-09-18 | |
US10/944,528 US8153159B2 (en) | 2003-09-18 | 2004-09-17 | Modafinil modified release pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AR046410A1 true AR046410A1 (es) | 2005-12-07 |
Family
ID=34381093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040103336A AR046410A1 (es) | 2003-09-18 | 2004-09-17 | Composiciones farmaceuticas para la liberacion modificada de modafinilo |
Country Status (21)
Country | Link |
---|---|
US (1) | US8153159B2 (es) |
EP (1) | EP1670447B1 (es) |
JP (1) | JP5138932B2 (es) |
KR (1) | KR20060117910A (es) |
AR (1) | AR046410A1 (es) |
AT (1) | ATE448780T1 (es) |
AU (1) | AU2004274017B2 (es) |
BR (1) | BRPI0414299A (es) |
CA (1) | CA2536666C (es) |
DE (1) | DE602004024220D1 (es) |
EA (1) | EA011400B1 (es) |
ES (1) | ES2336215T3 (es) |
HK (1) | HK1089697A1 (es) |
IL (1) | IL173738A (es) |
IS (1) | IS2787B (es) |
MX (1) | MXPA06003125A (es) |
MY (1) | MY144755A (es) |
NO (1) | NO20060964L (es) |
NZ (1) | NZ545573A (es) |
TW (1) | TWI344840B (es) |
WO (1) | WO2005027890A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ511442A (en) * | 1998-11-02 | 2003-02-28 | Elan Corp Plc | Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl |
ATE483455T1 (de) | 2004-05-28 | 2010-10-15 | Transform Pharmaceuticals Inc | Mischkristalle sowie sie enthaltende pharmazeutische zusammensetzungen |
WO2006063078A2 (en) * | 2004-12-08 | 2006-06-15 | Elan Corporation, Plc | Topiramate pharmaceuticals composition |
WO2007037790A2 (en) * | 2005-06-08 | 2007-04-05 | Elan Corporation, Plc | Modified release famciclovir compositions |
AU2007214487A1 (en) | 2006-02-13 | 2007-08-23 | Vanda Pharmaceuticals, Inc. | Stable dosage formulations of imidazolylalkyl-pyridines |
BRPI0714173A2 (pt) * | 2006-07-12 | 2012-12-25 | Elan Pharma Int Ltd | composiÇço nanoparticulada estÁvel,mÉtodos para preparar a composiÇço, para prevenir e/ou tratar estados de doenÇas, sintomas, sÍndromes e condiÇÕes do sistema nervoso central, para melhorar ou manter a biodisponibilidade de modafinil, e para tratar distérbio com base neurolàgica, composiÇço farmacÊutica, e forma de dosagem |
DE102006035549A1 (de) | 2006-07-27 | 2008-01-31 | Evonik Röhm Gmbh | Arzneiform mit mindestens zweischichtiger Trennschicht |
US20090082461A1 (en) * | 2007-09-25 | 2009-03-26 | Protia, Llc | Deuterium-enriched modafinil |
JP5250285B2 (ja) * | 2008-03-26 | 2013-07-31 | 富士フイルム株式会社 | 経口物用被覆材、可食性容器およびそれらを用いた経口物 |
WO2010012407A1 (en) * | 2008-07-29 | 2010-02-04 | Ashland Licensing And Intellectual Property Llc. | Modified additives for suppressing dust formation |
KR101465077B1 (ko) * | 2010-07-06 | 2014-11-26 | 주식회사 네비팜 | 다폭세틴을 포함하는 시간차 서방출 경구투여형 약학적 조성물 |
US8999393B1 (en) * | 2013-01-09 | 2015-04-07 | Edgemont Pharmaceuticals Llc | Sustained release formulations of lorazepam |
WO2015166473A1 (en) | 2014-05-01 | 2015-11-05 | Sun Pharmaceutical Industries Limited | Extended release suspension compositions |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5534263A (en) * | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
US6346548B1 (en) * | 1999-08-16 | 2002-02-12 | Cephalon, Inc. | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
US6458384B2 (en) * | 2000-02-23 | 2002-10-01 | Impetus Ag | Pharmaceutical with predetermined activity profile |
US6492396B2 (en) | 2000-05-16 | 2002-12-10 | Cephalon, Inc. | Substituted thioacetamides |
US6489363B2 (en) * | 2000-10-11 | 2002-12-03 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
US6344215B1 (en) * | 2000-10-27 | 2002-02-05 | Eurand America, Inc. | Methylphenidate modified release formulations |
US7141555B2 (en) | 2000-12-19 | 2006-11-28 | Cephalon, Inc. | Modafinil compound and cyclodextrin mixtures |
US7297346B2 (en) | 2001-05-25 | 2007-11-20 | Cephalon Inc. | Pharmaceutical formulations of modafinil |
GB0117618D0 (en) | 2001-07-19 | 2001-09-12 | Phoqus Ltd | Pharmaceutical dosage form |
US7229644B2 (en) * | 2002-05-23 | 2007-06-12 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
US20040116532A1 (en) | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
-
2004
- 2004-09-17 US US10/944,528 patent/US8153159B2/en not_active Expired - Fee Related
- 2004-09-17 AR ARP040103336A patent/AR046410A1/es unknown
- 2004-09-20 DE DE602004024220T patent/DE602004024220D1/de active Active
- 2004-09-20 AT AT04788862T patent/ATE448780T1/de not_active IP Right Cessation
- 2004-09-20 JP JP2006527123A patent/JP5138932B2/ja not_active Expired - Fee Related
- 2004-09-20 NZ NZ545573A patent/NZ545573A/en unknown
- 2004-09-20 KR KR1020067005361A patent/KR20060117910A/ko not_active Application Discontinuation
- 2004-09-20 EP EP04788862A patent/EP1670447B1/en active Active
- 2004-09-20 WO PCT/US2004/030815 patent/WO2005027890A1/en active Search and Examination
- 2004-09-20 MX MXPA06003125A patent/MXPA06003125A/es active IP Right Grant
- 2004-09-20 CA CA2536666A patent/CA2536666C/en not_active Expired - Fee Related
- 2004-09-20 BR BRPI0414299-3A patent/BRPI0414299A/pt not_active IP Right Cessation
- 2004-09-20 MY MYPI20043844A patent/MY144755A/en unknown
- 2004-09-20 TW TW093128394A patent/TWI344840B/zh not_active IP Right Cessation
- 2004-09-20 AU AU2004274017A patent/AU2004274017B2/en not_active Ceased
- 2004-09-20 ES ES04788862T patent/ES2336215T3/es active Active
- 2004-09-20 EA EA200600590A patent/EA011400B1/ru not_active IP Right Cessation
-
2006
- 2006-02-14 IL IL173738A patent/IL173738A/en not_active IP Right Cessation
- 2006-02-23 IS IS8327A patent/IS2787B/is unknown
- 2006-02-28 NO NO20060964A patent/NO20060964L/no not_active Application Discontinuation
- 2006-10-23 HK HK06111632.5A patent/HK1089697A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL173738A (en) | 2012-07-31 |
ES2336215T3 (es) | 2010-04-09 |
HK1089697A1 (en) | 2006-12-08 |
IS2787B (is) | 2012-06-15 |
EP1670447B1 (en) | 2009-11-18 |
IL173738A0 (en) | 2006-07-05 |
MY144755A (en) | 2011-10-31 |
MXPA06003125A (es) | 2006-06-20 |
DE602004024220D1 (de) | 2009-12-31 |
IS8327A (is) | 2006-02-23 |
TW200520748A (en) | 2005-07-01 |
AU2004274017B2 (en) | 2010-07-08 |
US8153159B2 (en) | 2012-04-10 |
CA2536666A1 (en) | 2005-03-31 |
TWI344840B (en) | 2011-07-11 |
NZ545573A (en) | 2010-02-26 |
US20050095294A1 (en) | 2005-05-05 |
ATE448780T1 (de) | 2009-12-15 |
BRPI0414299A (pt) | 2006-11-14 |
CA2536666C (en) | 2012-06-19 |
JP5138932B2 (ja) | 2013-02-06 |
JP2007518696A (ja) | 2007-07-12 |
EA011400B1 (ru) | 2009-02-27 |
EP1670447A1 (en) | 2006-06-21 |
EA200600590A1 (ru) | 2006-08-25 |
NO20060964L (no) | 2006-04-18 |
WO2005027890A1 (en) | 2005-03-31 |
KR20060117910A (ko) | 2006-11-17 |
AU2004274017A1 (en) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR111572A2 (es) | Formas farmacéuticas que contienen vardenafilo | |
AR045972A1 (es) | Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas | |
UY27533A1 (es) | Composiciones farmacéuticas que contienen oxibutinina | |
CO5640120A2 (es) | Formulacion y metodods para el tratamiento de trombocitemia | |
CO6241170A2 (es) | Administracion de oligonucleotidos antisentido complementarios a la apolipoproteina b humana | |
CR8352A (es) | Formulaciones farmaceuticas, procedimientos y pautas de dosificacion para el tratamiento y prevencion de sindromes coronarios agudos | |
AR049985A1 (es) | Tratamiento de combinacion para enfermedades malignas no hematologicas | |
UY26635A1 (es) | Métodos sinérgicos y composiciones para el tratamiento del cáncer | |
ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
AR046410A1 (es) | Composiciones farmaceuticas para la liberacion modificada de modafinilo | |
AR075423A1 (es) | Composicion farmaceutica que comprende un inhibidor de sglt-2, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y sus usos | |
AR050418A1 (es) | Dosificacion fija de anticuerpos her | |
CR6458A (es) | Composiciones de valdecoxib | |
NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
CO6260019A2 (es) | Metodos para el tratamiento de desordenes gastrointestinales independientes de la ingesta de alimento | |
AR033688A1 (es) | Composicion parenteral reconstituible | |
AR030039A1 (es) | Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento | |
RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
JP2009542623A5 (es) | ||
CN107205959A (zh) | 靶向在超增强子区域的转录控制的方法 | |
BRPI0415953A (pt) | formulação de dosagem de liberação controlada oral, método de tratamento de um distúrbio, conjunto de formas de dosagem de liberação controlada e método para administração da formulação | |
UA93365C2 (ru) | Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты) | |
PE20030830A1 (es) | Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea | |
JPH10505087A (ja) | 非麻薬性鎮痛剤および無痛エンハンサーを含有する疼痛緩和組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |